Filana Therapeutics Inc (FLNA)

Finanzdaten der Filana Therapeutics Inc-Aktie (FLNA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	17.59%11.17	13.55	11.86	45.39	24.59
Research and Development	17.93%4.54	3.85	3.96	5.12	13.67
Operating Income/Loss	17.59%-11.17	-13.55	-11.86	-45.39	-24.59
Income Tax Expense/Benefit	-	-	-	-	-
	17.61%-10.33	-12.54	-10.81	-44.22	-23.40
Attributable To Parent	17.61%-10.33	-12.54	-10.81	-44.22	-23.40
Basic Earnings Per Share	-0.21	-	-0.22	-0.92	-0.48